Xenon Pharmaceuticals Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Xenon Pharmaceuticals Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • Xenon Pharmaceuticals Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $214M, a 30.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $214M +$49.8M +30.2% Dec 31, 2023 10-K 2024-02-29
Q4 2022 $165M +$35.6M +27.6% Dec 31, 2022 10-K 2024-02-29
Q4 2021 $129M +$29M +29% Dec 31, 2021 10-K 2024-02-29
Q4 2020 $100M +$9.31M +10.2% Dec 31, 2020 10-K 2023-03-01
Q4 2019 $90.8M +$11.3M +14.2% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $79.5M +$11.9M +17.6% Dec 31, 2018 10-K 2020-03-09
Q4 2017 $67.6M +$9.21M +15.8% Dec 31, 2017 10-K 2019-03-06
Q4 2016 $58.4M +$6.9M +13.4% Dec 31, 2016 10-K 2018-03-07
Q4 2015 $51.5M +$2.48M +5.06% Dec 31, 2015 10-K 2017-03-08
Q4 2014 $49M -$2.36M -4.6% Dec 31, 2014 10-K 2016-03-08
Q4 2013 $51.4M Dec 31, 2013 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.